Accelerated Approval - Taking the FDA's Concerns Seriously

Accelerated Approval User-fee reauthorization creates new opportunities for the FDA to address issues with its accelerated-approval program, including the lack of evidence of clinical benefit for some products.

Automated summary

The reauthorization of the Accelerated Approval User-fee creates new opportunities for the FDA to address issues in its accelerated-approval program.